Related Experiment Videos
Progress in prostate cancer chemoprevention: modulators of promotion and progression
R Lieberman1, C Bermejo, H Akaza
1Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
Urology
|December 18, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Verification and Validation of Digital Pathology (Whole Slide Imaging) for Primary Histopathological Diagnosis: All Wales Experience.
Journal of pathology informatics·2021
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.
Cancer treatment and research communications·2019
Classification of Uterine Anomalies by 3-Dimensional Ultrasonography Using ESHRE/ESGE Criteria: Interobserver Variability.
Reproductive sciences (Thousand Oaks, Calif.)·2017
Non-visualization of choroid plexus of fourth ventricle as first-trimester predictor of posterior fossa anomalies and chromosomal defects.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2017
Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Henry Bugbee and His Eponymous Electrode.
Urology·2026
Frailty Assessment and Its Impact in Hospital Outcomes After Cardiac Surgery - A Prospective Observational Study.
Brazilian journal of cardiovascular surgery·2026
Changes in Susceptibility to Cannabis Use From Late Childhood to Early Adolescence.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2026
Comparing methodological approaches for outlier detection: a cross-sectional study of older persons in 2,744 Australian long-term care facilities.
International journal for quality in health care : journal of the International Society for Quality in Health Care·2026
FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland.
Acta oncologica (Stockholm, Sweden)·2026